6 years ago

Flow Raises Funding to Rollout Depression Treatment in Europe

  • Flow, a London-based medical device company, has raised $1.5 million in funding from Khosla Ventures to support the European rollout and introduction to healthcare clinics, and the conduction of clinical studies.

      • ProblemHealthcare

      "Flow is addressing the challenge of providing effective, at-home treatment for depression, aiming to make treatment more accessible and flexible for individuals experiencing depression."

      Solution

      "Flow offers a comprehensive solution through a portable brain stimulation headset and a therapy app. The headset uses transcranial direct current stimulation (tDCS) to stimulate and rebalance neural activity, while the app provides educational videos and advice on managing depression through sleep, nutrition, fitness, and meditation."

      Covered on